We Embody a Legacy of Incredible Discoveries, Exploring the Boundaries of Innovation and Science
At Zenovel, we integrate our extensive expertise across a wide range of domains, from Good Clinical Practice to Regulatory Affairs, to present valuable insights and thought leadership. Each blog reflects our intense dedication to innovation, offering a forum to share our perspectives, groundbreaking ideas, and industry expertise. Through our blogs, we hope to uplift, inform, and support scientific, medical, and pharmaceutical innovation.
The recent update of ICH E6(R3) marks a significant evolution in clinical trial execution, transitioning from a compliance-centric approach to
In the pharmaceutical industry, particularly in India’s expanding market, the regulatory pathway is a crucial determinant that influences the transition
In the current pharmaceutical environment, the integrity of a company’s supply chain relies heavily on its weakest link, particularly concerning
In clinical research, Good Clinical Practice (GCP) sets ethical and quality standards. Non-compliance during audits poses systemic risks to patient
The pharmaceutical industry relies on innovation, but not all companies can fully develop a drug. Strategic licensing, including In-Licensing and
The announcement of a Good Manufacturing Practice (GMP) audit often instills anxiety among pharmaceutical, biotech, or medical device facilities. The
We provide affordable, innovative, and high-quality solutions to pharma industry with ethics driven research and increasing accessibility to high quality medicine worldwide
Copyright © 2024 Zenovel. All rights reserved.
